Chong Kun Dang Pharmaceutical
185750.KO
54.47 USD
-0.52
-0.95%
c
Overview
Last close
54.47 usd
Market cap
717.64M usd
52 week high
71.25 usd
52 week low
48.18 usd
Target price
79.93 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.2348
Price/Book Value
1.0869
Enterprise Value
746.03M usd
EV/Revenue
0.6572
EV/EBITDA
8.3533
Key financials
Revenue TTM
576.88M usd
Gross Profit TTM
229.02M usd
EBITDA TTM
66.86M usd
Earnings per Share
N/A usd
Dividend
0.34 usd
Total assets
1.25B usd
Net debt
98.28M usd
About
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
- Symbol185750.KO
- ExchangeKO
- IsinKR7185750007
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Young-Joo Kim
- HeadquarterSeoul
- Web sitehttps://www.ckdpharm.com
Related indices
Related news
November 18
JAKOTA Stocks on November 17, 2023 